CareMax, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMAX research report →
About the company
CareMax, Inc. delivers a broad spectrum of medical services to patients, facilitated by its network of physicians and healthcare professionals. The company offers a comprehensive array of medical and social support programs, which includes general practice, specialized treatments, remote healthcare consultations, wellness initiatives, vision care, dental services, prescription fulfillment, and transportation assistance.
- CEO
- Carlos A. de Solo
- IPO
- 2020
- Employees
- 1,450
- HQ
- Miami, FL, US
Price Chart
- Market Cap
- $1.61M
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.03
- EV/EBITDA
- -0.74
- Div Yield
- 0.00%
- Gross Margin
- 1.85%
- Op Margin
- -87.36%
- Net Margin
- -90.98%
- ROE
- -200.69%
- ROIC
- -115.61%
- Revenue
- $751.10M · 19.01%
- Net Income
- $-683,348,000 · -1707.94%
- EPS
- $-183.30 · -1367.57%
- Op Income
- $-656,152,000
- FCF YoY
- 18.69%
- 52W High
- $0.52
- 52W Low
- $0.42
- 50D MA
- $0.02
- 200D MA
- $1.64
- Beta
- 0.68
- Avg Volume
- 1.22M
Get TickerSpark's AI analysis on CMAX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 24, 24 | BORKOWSKI EDWARD | other | 0 |
| Jun 10, 24 | Rundell Paul Brent | other | 0 |
| Nov 17, 23 | Flynn James E | other | 12,123 |
| Nov 17, 23 | Flynn James E | other | 12,123 |
| Nov 17, 23 | Berg Kevin | other | 12,123 |
| Nov 17, 23 | Berg Kevin | other | 12,123 |
| Nov 17, 23 | de la Torre Ralph | other | 10,927 |
| Nov 17, 23 | de la Torre Ralph | other | 10,927 |
| Nov 17, 23 | OQuinn Ryan | other | 12,123 |
| Nov 17, 23 | OQuinn Ryan | other | 12,123 |
Our CMAX coverage
Recent articles, reports, and earnings notes.
No research on CMAX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMAX report →Similar companies
Peers in the same neighborhood.